Published in Am J Cardiovasc Drugs on January 01, 2007
Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology (2010) 1.24
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond) (2012) 1.04
Primary stroke prevention and hypertension treatment: which is the first-line strategy? Neurol Int (2011) 0.84
Candesartan prevents impairment of recall caused by repeated stress in rats. Psychopharmacology (Berl) (2012) 0.78
Regulation of oxidative stress and cardioprotection in diabetes mellitus. Curr Cardiol Rev (2008) 0.77
Angiotensin converting enzyme inhibition reduces cardiovascular responses to acute stress in myocardially infarcted and chronically stressed rats. Biomed Res Int (2014) 0.75
A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention. Vasc Health Risk Manag (2009) 0.75
The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke (2003) 4.63
Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol (2004) 3.18
Organotypic slice culture from human adult ventricular myocardium. Cardiovasc Res (2011) 1.78
Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*. J Hypertens (2006) 1.74
Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension (2003) 1.61
Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens (2002) 1.54
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension. J Hypertens (2003) 1.53
Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform. Cardiovasc Res (2002) 1.31
Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol (2003) 1.19
Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway. J Cardiovasc Pharmacol (2004) 1.17
Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J (2003) 1.09
Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet (2011) 1.08
Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? Int J Biochem Cell Biol (2003) 1.01
Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Cardiovasc Res (2007) 0.98
Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc Res (2004) 0.97
Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins. J Biol Chem (2010) 0.96
Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats. Endocrinology (2006) 0.94
Non-hypoxic induction of HIF-3alpha by 2-deoxy-D-glucose and insulin. Biochem Biophys Res Commun (2006) 0.94
Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol (2002) 0.91
Calcitonin gene related peptide mediates cardioprotection by remote preconditioning. Regul Pept (2005) 0.90
Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. FASEB J (2004) 0.88
Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation. J Clin Invest (2014) 0.87
Role of neuronal KATP channels and extraneuronal monoamine transporter on norepinephrine overflow in a model of myocardial low flow ischemia. J Pharmacol Exp Ther (2004) 0.87
Organ-specific extravasation of albumin-bound Evans blue during nonresuscitated hemorrhagic shock in rats. Shock (2003) 0.85
Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism. J Pharmacol Exp Ther (2002) 0.84
Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats. Brain Res (2007) 0.84
Truncating mutations in THAP1 define the nuclear localization signal. Mov Disord (2011) 0.84
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction. Eur J Pharmacol (2006) 0.84
Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure. Circulation (2002) 0.83
Cardiac kinin level in experimental diabetes mellitus: role of kininases. Am J Physiol Heart Circ Physiol (2003) 0.82
Long-term results of autologous submandibular gland transfer for the surgical treatment of severe keratoconjunctivitis sicca. J Craniomaxillofac Surg (2008) 0.81
Radioprotective effect of lidocaine on function and ultrastructure of salivary glands receiving fractionated radiation. Int J Radiat Oncol Biol Phys (2012) 0.81
Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors. Endocrinology (2003) 0.81
Pioglitazone prevents capillary rarefaction in streptozotocin-diabetic rats independently of glucose control and vascular endothelial growth factor expression. J Vasc Res (2012) 0.80
Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells. Am J Physiol Regul Integr Comp Physiol (2009) 0.80
Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation. Hypertension (2004) 0.80
Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction size. Can J Physiol Pharmacol (2006) 0.79
Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model. Biol Chem (2008) 0.79
Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? Basic Res Cardiol (2002) 0.79
An unusual case of hyponatraemia. Nephrol Dial Transplant (2009) 0.77
Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy? J Hypertens (2005) 0.77
AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats. FASEB J (2002) 0.76
Impairment of presynaptic alpha2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty rats. J Cardiovasc Pharmacol (2006) 0.76
Adrenal expression of orexin receptor subtypes is differentially regulated in experimental streptozotocin induced type-1 diabetes. Peptides (2006) 0.75
Radioprotective effect of lidocaine on neurotransmitter agonist-induced secretion in irradiated salivary glands. PLoS One (2013) 0.75
Prophylactic gamma radiation of unaffected vein grafts failed to prevent vein graft disease in a chronic hypercholesterolemic porcine model. Eur J Cardiothorac Surg (2003) 0.75
Calcitonin gene-related peptide does not interact with sympathetic activity in myocardial ischemia. Regul Pept (2005) 0.75
Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on cardiac norepinephrine release: comparison between ischemic and nonischemic conditions. J Cardiovasc Pharmacol (2002) 0.75
Acute hypothalamo-pituitary-adrenal axis response to LPS-induced endotoxemia: expression pattern of kinin type B1 and B2 receptors. Biol Chem (2016) 0.75
Upregulation of the high mobility group AT-hook 2 gene in acute aortic dissection is potentially associated with endothelial-mesenchymal transition. Histol Histopathol (2011) 0.75
Expression of kinin receptor mRNA in the HPA axis of type 1 and type 2 diabetic rats. Int Immunopharmacol (2004) 0.75
Adenylyl cyclase-dependent inhibition of myocardial norepinephrine release by presynaptic adenosine A1-receptors. J Cardiovasc Pharmacol (2005) 0.75